A new study reveals a novel approach to mitigating tissue damage caused by Streptococcus pyogenes, the flesh-eating bacterium responsible for severe infections such as necrotizing fasciitis. The ...

A new study published in Nature Communications reveals a novel approach to mitigating tissue damage caused by Streptococcus ...

Although most manufacturer reports of medical device adverse events are reported on time, a considerable proportion are submitted late.

Under federal law, device makers must submit adverse event reports they receive from patients to the FDA’s Manufacturer And User Facility Device Experience (MAUDE) database within 30 days, researchers ...

BioClec, a cutting-edge biotechnology company focused on breakthrough therapies for Alzheimer's disease (AD), announces its launch today. Emerging from Sofinnova Partners' ?165M Biovelocita II ...

A new study published in Nature Communications reveals a novel approach to mitigating tissue damage caused by Streptococcus pyogenes, the flesh-eating ...

Researchers tested computational predictions by peering into condensates using novel super-resolution microscopy methods.

Strong support from pharma groups including Amgen, Bristol Myers Squibb and Pfizer has allowed European venture capital firm Sofinnova Partners to close a new biotech fund with €165 million ($180 ...

The unraveling of Marc and Alain Cohens' relationship with Dana-Farber — where Marc was also a trustee — has created possible legal problems for the hospital.

Raziel Green, 52, an active runner and mother of two, was diagnosed with a rare form of ALS in 2017. Since starting a clinical trial nearly eight years ago, her symptoms have not gotten any worse.

The University of Kansas is among 45 universities that the U.S. Department of Education is investigating related to concerns ...

Nobel Laureate and University of Chicago professor Jack Szostak delivered two lectures on the origin of life to an audience of professors, graduate, and undergraduate students the Monday and Tuesday ...